Sana Biotechnology, Inc.
SANA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $376,352 | $793,727 | $743,959 | $2,576,383 |
| - Cash | $127,566 | $133,517 | $176,765 | $253,029 |
| + Debt | $94,197 | $104,096 | $108,253 | $110,943 |
| Enterprise Value | $342,983 | $764,306 | $675,447 | $2,434,297 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$255,332 | -$268,584 | -$256,939 | -$345,839 |
| % Margin | – | – | – | – |
| Net Income | -$266,759 | -$283,255 | -$269,476 | -$355,928 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.16 | -1.46 | -1.43 | -2.14 |
| % Growth | 20.5% | -2.1% | 33.2% | – |
| Operating Cash Flow | -$223,153 | -$253,582 | -$290,050 | -$251,054 |
| Capital Expenditures | -$33,430 | -$20,032 | -$20,876 | -$29,862 |
| Free Cash Flow | -$256,583 | -$273,614 | -$310,926 | -$280,916 |